ATA10872004A - Pharmazeutische zubereitung zur behandlung von schock - Google Patents

Pharmazeutische zubereitung zur behandlung von schock

Info

Publication number
ATA10872004A
ATA10872004A AT0108704A AT10872004A ATA10872004A AT A10872004 A ATA10872004 A AT A10872004A AT 0108704 A AT0108704 A AT 0108704A AT 10872004 A AT10872004 A AT 10872004A AT A10872004 A ATA10872004 A AT A10872004A
Authority
AT
Austria
Prior art keywords
shock
treatment
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
AT0108704A
Other languages
English (en)
Other versions
AT414097B (de
Original Assignee
Petzelbauer Peter Dr
Zacharowski Kai Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AT0108704A priority Critical patent/AT414097B/de
Application filed by Petzelbauer Peter Dr, Zacharowski Kai Dr filed Critical Petzelbauer Peter Dr
Priority to SI200530842T priority patent/SI1691827T1/sl
Priority to UAA200604047A priority patent/UA91497C2/ru
Priority to HK06114161.8A priority patent/HK1093308B/xx
Priority to DE502005007926T priority patent/DE502005007926D1/de
Priority to DK05752350T priority patent/DK1691827T3/da
Priority to PL05752350T priority patent/PL1691827T3/pl
Priority to CA002544676A priority patent/CA2544676A1/en
Priority to CNA2005800009931A priority patent/CN1842344A/zh
Priority to EA200600561A priority patent/EA008799B1/ru
Priority to EP05752350A priority patent/EP1691827B1/de
Priority to PCT/AT2005/000228 priority patent/WO2006000007A1/de
Priority to BRPI0506148-2A priority patent/BRPI0506148A/pt
Priority to JP2007516870A priority patent/JP2008503503A/ja
Priority to NZ545634A priority patent/NZ545634A/en
Priority to AU2005256121A priority patent/AU2005256121B2/en
Priority to AT05752350T priority patent/ATE439856T1/de
Priority to HR20090618T priority patent/HRP20090618T1/hr
Priority to ZA200602053A priority patent/ZA200602053B/en
Priority to US10/596,103 priority patent/US20080249006A1/en
Priority to ES05752350T priority patent/ES2331958T3/es
Priority to PT05752350T priority patent/PT1691827E/pt
Publication of ATA10872004A publication Critical patent/ATA10872004A/de
Priority to IL173969A priority patent/IL173969A/en
Application granted granted Critical
Publication of AT414097B publication Critical patent/AT414097B/de
Priority to CY20091101198T priority patent/CY1109631T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT0108704A 2004-06-25 2004-06-25 Pharmazeutische zubereitung zur behandlung von schock AT414097B (de)

Priority Applications (24)

Application Number Priority Date Filing Date Title
AT0108704A AT414097B (de) 2004-06-25 2004-06-25 Pharmazeutische zubereitung zur behandlung von schock
JP2007516870A JP2008503503A (ja) 2004-06-25 2005-06-24 ヒトフィブリノゲンのＡα鎖またはＢβ鎖由来のペプチドの、ショックの治療のための利用
HK06114161.8A HK1093308B (en) 2004-06-25 2005-06-24 Use of peptides derived from the b beta chain of human fibrinogen for the treatment of shock
DE502005007926T DE502005007926D1 (de) 2004-06-25 2005-06-24 Verwendung von peptiden, die aus der b beta kette des humanen fibrinogens abgeleitet wurden, zur behandlung von schock
DK05752350T DK1691827T3 (da) 2004-06-25 2005-06-24 Anvendelse af peptider, der er afledt fra beta-kæden af det humane fibrinogen, til behandlling af shock
PL05752350T PL1691827T3 (pl) 2004-06-25 2005-06-24 Zastosowanie peptydów pochodzących z łańcucha beta ludzkiego fibrynogenu do leczenia wstrząsu
CA002544676A CA2544676A1 (en) 2004-06-25 2005-06-24 Use of peptides derived from the a alpha or b beta chain of human fibrinogen for the treatment of shock
CNA2005800009931A CN1842344A (zh) 2004-06-25 2005-06-24 衍生自人血纤维蛋白原的Aα或Bβ链的肽用于治疗休克的用途
EA200600561A EA008799B1 (ru) 2004-06-25 2005-06-24 Фармацевтический препарат для лечения шока
EP05752350A EP1691827B1 (de) 2004-06-25 2005-06-24 Verwendung von peptiden, die aus der b beta kette des humanen fibrinogens abgeleitet wurden, zur behandlung von schock
PCT/AT2005/000228 WO2006000007A1 (de) 2004-06-25 2005-06-24 Verwendung von peptiden, die aus der a alpha oder der b beta kette des humanen fibrinogens abgeleitet wurden, zur behandlung von schock
BRPI0506148-2A BRPI0506148A (pt) 2004-06-25 2005-06-24 preparação farmacêutica para o tratamento de choque
SI200530842T SI1691827T1 (sl) 2004-06-25 2005-06-24 Uporaba peptidov, izvedenih iz Bbeta-verige človeškega fibrinogena, za zdravljenje šoka
NZ545634A NZ545634A (en) 2004-06-25 2005-06-24 Use of peptides derived from the A alpha or B beta chain of human fibrinogen for the treatment of shock
US10/596,103 US20080249006A1 (en) 2004-06-25 2005-06-24 Pharmaceutical Preparation for the Treatment of Shock
AT05752350T ATE439856T1 (de) 2004-06-25 2005-06-24 Verwendung von peptiden, die aus der b beta kette des humanen fibrinogens abgeleitet wurden, zur behandlung von schock
HR20090618T HRP20090618T1 (hr) 2004-06-25 2005-06-24 Uporaba peptida koji proizlaze iz b beta lanca humanog fibrinogena za liječenje šoka
ZA200602053A ZA200602053B (en) 2004-06-25 2005-06-24 Use of peptides derived from the A alpha or B beta chain of human fibrinogen for the treatment of shock
AU2005256121A AU2005256121B2 (en) 2004-06-25 2005-06-24 Use of peptides derived from the A alpha or B beta chain of human fibrinogen for the treatment of shock
UAA200604047A UA91497C2 (ru) 2004-06-25 2005-06-24 ПРИМЕНЕНИЕ ПЕПТИДОВ, ВЫДЕЛЕННЫХ ИЗ ЦЕПИ Bb ЧЕЛОВЕЧЕСКОГО ФИБРИНОГЕНА, ДЛЯ ЛЕЧЕНИЯ ШОКА
PT05752350T PT1691827E (pt) 2004-06-25 2005-06-24 Utilização de péptidos derivados da cadeia b beta de fibrinogénio humano para o tratamento do choque
ES05752350T ES2331958T3 (es) 2004-06-25 2005-06-24 Uso de peptidos derivados de la cadena b beta de fibrinogeno humano para el tratamiento del choque.
IL173969A IL173969A (en) 2004-06-25 2006-02-27 Use of peptides derived from the b beta chain of human fibrinogen for the preparation of pharmaceutical compositions for treatment of shock
CY20091101198T CY1109631T1 (el) 2004-06-25 2009-11-13 Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0108704A AT414097B (de) 2004-06-25 2004-06-25 Pharmazeutische zubereitung zur behandlung von schock

Publications (2)

Publication Number Publication Date
ATA10872004A true ATA10872004A (de) 2005-12-15
AT414097B AT414097B (de) 2006-09-15

Family

ID=35508712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0108704A AT414097B (de) 2004-06-25 2004-06-25 Pharmazeutische zubereitung zur behandlung von schock

Country Status (4)

Country Link
CN (1) CN1842344A (de)
AT (1) AT414097B (de)
UA (1) UA91497C2 (de)
ZA (1) ZA200602053B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT502987A1 (de) 2005-12-23 2007-07-15 Fibrex Medical Res & Dev Gmbh Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen
CN101937002A (zh) * 2010-07-23 2011-01-05 合肥天一生物技术研究所 血红蛋白目测试剂
KR20140138956A (ko) * 2012-03-15 2014-12-04 더 리서치 파운데이션 포 더 스테이트 유니버시티 오브 뉴욕 Ｅ-카드헤린의 세포외 도메인의 저해제를 포함하는 병용 치료법

Also Published As

Publication number Publication date
CN1842344A (zh) 2006-10-04
UA91497C2 (ru) 2010-08-10
AT414097B (de) 2006-09-15
ZA200602053B (en) 2007-06-27

Similar Documents

Publication Publication Date Title
LT2878297T (lt) Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai
DE602004028763D1 (de) Te zur behandlung von virenerkrankungen
EP1851237A4 (de) Pharmazeutische zusammensetzungen zur behandlung oder prävention von knochenerkrankungen
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DE602006019838D1 (de) Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
DK1853271T3 (da) Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme
ATE369333T1 (de) Sulfonamidderivate zur behandlung von krankheiten
DE602005019899D1 (de) System zur behandlung von ischämischem schlaganfall
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602006019468D1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
DE502005010499D1 (de) Implantat zur Behandlung von Fettsucht
EP1965827A4 (de) Behandlung von entmyelinisierenden erkrankungen
DE602007009877D1 (de) Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen
ATE482709T1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
NO20053348D0 (no) Farmasoytisk sammensetning for behandling av virusangrep.
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DE502006001195D1 (de) Transdermales therapeutisches system zur verabreichung von analgetika
ATE517877T1 (de) Neue arzneimittel zur behandlung von atemwegserkrankungen
ATE526970T1 (de) Behandlung von mastitis

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
MM01 Lapse because of not paying annual fees

Effective date: 20111215